Management of infections caused by multidrug-resistant gram-negative pathogens: recent advances and future directions

M Bassetti, A Vena, DR Giacobbe… - Archives of medical …, 2021 - Elsevier
During the last decades, the isolation of multidrug-resistant Gram-negative (MDR-GN)
bacteria has dramatically increased worldwide and has been associated with significant …

Mortality associated with bacteremia due to colistin-resistant Klebsiella pneumoniae with high-level meropenem resistance: importance of combination therapy without …

I Machuca, B Gutierrez-Gutierrez… - Antimicrobial agents …, 2017 - Am Soc Microbiol
Combination therapy including colistin and a carbapenem has been found to be associated
with lower mortality in the treatment of bloodstream infections (BSI) due to KPC-producing …

Multidrug-resistant bacterial infections in solid organ transplant candidates and recipients

M Bartoletti, M Giannella, S Tedeschi… - Infectious Disease …, 2018 - id.theclinics.com
The advancements in surgical techniques, immunosuppressive therapies, and infection
control and prophylaxis, along with significant changes in the policy of graft recruitment and …

The role of colistin in the era of new β-lactam/β-lactamase inhibitor combinations

AT Aslan, M Akova - Antibiotics, 2022 - mdpi.com
With the current crisis related to the emergence of carbapenem-resistant Gram-negative
bacteria (CR-GNB), classical treatment approaches with so-called “old-fashion antibiotics” …

Carbapenem-resistant Enterobacterales: considerations for treatment in the era of new antimicrobials and evolving enzymology

MJ Lasko, DP Nicolau - Current infectious disease reports, 2020 - Springer
Abstract Purpose of Review Gram-negative resistance is a growing concern globally.
Enterobacterales, formerly Enterobacteriaceae, have developed resistance mechanisms to …

[HTML][HTML] Klebsiella pneumoniae in Singapore: Hypervirulent Infections and the Carbapenemase Threat

KL Chew, RTP Lin, JWP Teo - Frontiers in Cellular and Infection …, 2017 - frontiersin.org
Klebsiella pneumoniae remains a major pathogen responsible for localized infections such
as cystitis and pneumonia, and disseminated infections that may result in severe sepsis and …

The epidemiology, evolution, and treatment of KPC-producing organisms

AM Porreca, KV Sullivan, JC Gallagher - Current infectious disease reports, 2018 - Springer
Abstract Purpose of Review The purpose of this review is to investigate the evolution and
epidemiology of Klebsiella pneumoniae carbapenemase (KPC)-producing organisms and …

CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional …

JE Cañada-García, Z Moure, PJ Sola-Campoy… - Frontiers in …, 2022 - frontiersin.org
Objectives CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating
whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K …

Risk factors and outcomes of endocarditis due to non-HACEK gram-negative bacilli: data from the prospective multicenter Italian endocarditis study cohort

M Falcone, G Tiseo, E Durante-Mangoni… - Antimicrobial agents …, 2018 - Am Soc Microbiol
The objective of this study was to investigate predisposing factors and outcomes of infective
endocarditis (IE) caused by non-HACEK Gram-negative bacilli (GNB) in a contemporary …

An Emerging Clone, Klebsiellapneumoniae Carbapenemase 2–Producing K. pneumoniae Sequence Type 16, Associated With High Mortality Rates in a CC258 …

DO Andrey, P Pereira Dantas… - Clinical Infectious …, 2020 - academic.oup.com
Abstract Background Carbapenemase-producing Klebsiella pneumoniae has become a
global priority, not least in low-and middle-income countries. Here, we report the emergence …